Evidence Synthesis Manager

Within the Global HTA and Payers organisation, the
Evidence Synthesis Manager plays a key role in shaping how payer strategy is
translated into high -quality, decision -ready evidence and value communication
that supports asset and access success.

The role reports to the Evidence Synthesis Lead and works with relevant sub‑team
members to contribute to the development and implementation of agreed payer
strategy through global deliverables, particularly through the Market Access
Strategy Summary (MASS). The Manager provides evidence‑based inputs, drafting
support and integration of cross‑functional contributions, translating the
strategic direction set by the Evidence Synthesis Lead into coherent global
deliverables.

The role is accountable for leading the development and maintenance of core
payer evidence and value deliverables for assigned assets and indications,
working directly and/or through external partners as appropriate. It provides
significant exposure to asset -level strategy, cross -functional collaboration
and global–local interactions, and is designed as a development role for future
Market Access leaders.

Requirements

Payer Evidence
and Value Deliverables
• Accountable for the development, maintenance and timely delivery of core
payer evidence and value deliverables for assigned assets/indications,
including Global Value Dossiers (GVDs), Detailed Assessment Reports (DARs),
value narratives and objection handlers.
• Deliver these outputs directly and/or through effective management of
external partners, retaining accountability for quality, consistency,
integration and timelines.

Market Access
Strategy Summary (MASS) Enablement
• Develop and maintain payer evidence and value deliverables in line with the
agreed Market Access Strategy Summary (MASS), ensuring consistency with the
strategic direction set by the Market Access Strategy Lead.
• Provide evidence based inputs and drafting support that help translate
strategic assumptions, scenarios, access risks and trade offs into decision
ready materials.

Cross functional Evidence Alignment
• Identify payer relevant evidence gaps and access risks and coordinate with
Health Economics and Real World Evidence colleagues to inform evidence
generation priorities.
• Provide structured evidence inputs to Health Economics and RWE leads for
inclusion in relevant evidence governance forums (e.g. ISEG), ensuring
consistency with agreed payer strategy.
Asset and Access Forum Support
• Support preparation of payer evidence and value narratives for key asset and
access forums (e.g. PSLT and asset strategy discussions), working through the
Market Access Strategy Lead and Access Strategy Leads.
• Contribute evidence based insights without owning forum governance or
decision making.